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(diabetes, coronary and peripheral artery disease), medications, and biochemical
parameters (HbA1c, CRP, albumin and lipids) did not influence patency.
Conclusion: Multiple stenoses and upper arm fistulae may be associated with
shorter patency after PTA. More large volume prospective studies are required to
further assess factors associated with patency after PTA in haemodialysis fistulae,
particularly the role of metabolic and inflammatory markers.
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CLINICAL OUTCOMES AFTER ARTERIOVENOUS
FISTULA CREATION IN PATIENTS WITH
CHRONIC KIDNEY DISEASE
M LEE, P MOUNT, M ROBERTS, M ROSS-SMITH, J CHUEN
Austin Health, Australia
Aim: Creation of an arteriovenous fistula (AVF) before initiation of haemodi-
alysis (HD) is an important goal in chronic kidney disease (CKD) management.
This study aims to determine outcomes and optimal timing for AVF creation in
CKD patients.
Methods: We reviewed records of all CKD patients who had a first AVF creation
for future HD at Austin Health from 01/01/2007–31/12/2009 and obtained
follow-up data until 31/12/2011. Survival analysis was performed for the primary
outcome of time from AVF creation to first HD treatment.
Results: In 100 patients who had a first AVF created, the mean age was
63.7 6 13.7 years, 49 had diabetes and 39 were female. Mean time from AVF
creation to first HD in 73 patients who commenced HD was 14.1 6 12.7 (range:
0.2–47.7) months. Of these 73 patients, 21 (29%) required a radiological and/or
surgical procedure before commencing HD and 26 (36%) required a procedure
within 3 months of commencing HD. Despite AVF creation, 12 (16%) patients
required a catheter to start HD and 2 (3%) required a catheter within 3 months
of HD commencement. Median time to starting HD was 479 days. In patients
with eGFR < 16 mL/min (the median) median time to starting dialysis was
321 days compared to 909 days for eGFR $ 16 ml/min (Log rank p = 0.018).
At 3, 6 and 12 months respectively, 20%, 44% and 56% of patients with
eGFR < 16 mL/min had commenced HD compared to 11%, 20% and 26% with
eGFR $ 16 ml/min.
Conclusion: While early AVF creation is an important goal, we demonstrate
that optimal timing of AVF creation is challenging, with half of our patients not
using the AVF for over a year, and many requiring subsequent AVF procedures
before becoming established on HD.
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OUTCOME OF PREDIALYSIS EDUCATION IN
WESTERN SYDNEY: EARLY REFERRAL IS
ASSOCIATED WITH REDUCED RATE OF LINE USE
AT FIRST DIALYSIS
T SMOLONOGOV, YM KUANG, L KAIRAITIS
Western Renal Service, Australia
Aim: To review characteristics and outcomes for patients referred to a compre-
hensive predialysis programme in Western Sydney.
Background: In 2005 theWestern Renal Service (WRS) appointed a Predialysis
coordinator to facilitate patient education, informed dialysis modality choice and
facilitate access planning. This programme was developed to promote home
dialysis therapies and minimise rates of unplanned dialysis commencement and
haemodialysis catheter use as initial dialysis access.
Methods: Patients referred for predialysis education between 2005–2010 and
who subsequently commenced dialysis were identified from the WRS predialysis
database. The proportions of these patients who ultimately undertook a home
dialysis therapy or commenced dialysis with permanent access were calculated
and related to the GFR at referral to this programme.
Results: 965 patients were referred to the predialysis programme in this period.
546 of these patients subsequently commenced maintenance dialysis; 72% of this
group ultimately undertook a home dialysis therapy. The average referral GFR
was 12.5 mL/min/1.73 m2, 74% were referred with a GFR of 15 mL/min/1.73 m2
and 92% with a GFR of 20 mL/min/1.73 m2 or less.
Patients who started dialysis with permanent dialysis access had a higher GFR
at referral than patients who commenced dialysis with a haemodialysis catheter
(13.4 vs 11.1, p < 0.01). Patients referred for predialysis interview with a GFR
more than 10 ml/min/1.73 m2 were more likely to commence dialysis with per-
manent dialysis access (p < 0.01). Rates of home dialysis did not appear to be
affected by the GFR at time of referral.
Conclusions: Despite the referral GFR being lower than recommended levels,
high rates of home dialysis uptake was achieved in patients referred to the
predialysis programme at WRS. Earlier referral is associated with a higher chance
of commencing dialysis with permanent access.
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FACTORS INFLUENCING HAEMODIALYSIS
ARTERIOVENOUS FISTULA PATENCY
AFTER BALLOON ANGIOPLASTY; A
SYSTEMATIC REVIEW
B NEUEN1, A WEBSTER2, R GUNNARSSON1, R BAER3, JP KILLEN3,
M MANTHA3
1James Cook University School of Medicine and Dentistry, Australia; 2Sydney
School of Public Health, The University of Sydney, Australia; 3Renal Services,
Cairns Base Hospital, Australia
Aim: Percutaneous transluminal angioplasty (PTA) is an established treatment
for haemodialysis fistula stenosis. This study aimed to systematically review evi-
dence for factors associated with patency after percutaneous transluminal angi-
oplasty (PTA).
Background: The effects of patient comorbidity, demographic, biochemical and
anatomical characteristics, with initial PTA success and post-intervention
patency have not previously been summarised.
Methods: We searched databases to identify studies assessing patency after PTA
in haemodialysis fistulae. Studies of immature or thrombosed fistulae or other
dialysis access were excluded. Quality of studies was assessed using a modified
validated checklist. Outcomes assessed were post-intervention primary and sec-
ondary patency, restenosis at 6 months, technical and clinical success, assisted
primary patency and mean interval or frequency of endovascular interventions
during follow up. Findings were summarized descriptively.
Results: We included 12 single-centre studies of 1 120 participants with 1281
fistulae. Follow-up ranged from 3 days-10years. Shorter primary patency was seen
with more recent fistulae (4 studies), longer stenosis length, upper arm fistulae (2
studies), small inflow artery diameter, arteriovenous anastomotic site and history
of previous endovascular interventions (1 study each). Shorter secondary patency
was seen with increased patient age (2 studies), and more recent fistulae (1 study).
Early restenosis was associated with diabetes (3 studies), HbA1c, low-density
lipoprotein, and asymmetric dimethylarginine (1 study each). Technical success
was reduced for upper arm fistulae and high-grade stenoses (1 study), while
clinical success of PTA was more likely in stenotic compared to thrombosed
fistulae (1 study).
Conclusion: Fistula characteristics and diabetes may be associated with poor
PTA outcomes, however evidence is inconclusive, and the role of metabolic and
inflammatory markers is unclear.
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IMPROVING VASCULAR ACCESS OUTCOMES AT
GOLD COAST
S THOKALA, D DU TOIT, T SNOW, M JACKSON, J KURTKOTI,
A PARNHAM, M DIVI, T TITUS, B HIREMAGALUR
Gold Coast Hospital, Australia
Background: A mature arteriovenous fistula (AVF) at the start of dialysis
reduces morbidity, mortality and costs compared to a cental venous catheter
(CVC). In 2005, less than 38% of our patients commenced haemodialysis with an
AVF and Central Line Associated Blood Stream Infection (CLABSI) rate asso-
ciated with our haemodialysis CVC’s was 3.5/1000 catheter days.
Aim: A multi-pronged intervention was developed with focus on a renal access
co-ordinator to expedite a “fistula first” approach and reduce complications asso-
ciated with HD CVC use by targeting incident (first dialysis) catheter rates and
CLABSI rates.
Methods: Outcome was assessed by 1. Proportion of patients starting dialysis
with a CVC. 2. Tunnelled Haemodialysis associated CLABSI rates per 1000
catheter days. 3. Proportion of patients on maintenance dialysis with a CVC. 4.
Non tunnelled haemodialysis catheter total yearly dwell days. 5. Proportion of
prevalent patients and incident patients with AVF.
Results: The proportion of patients commencing haemodialysis via a CVC
dropped from 62% in 2005 to 34% in 2012. The CLABSI Rate associated with
tunnelled Haemodialysis catheter use dropped from 3.5/ 1000 days in 2005 to
0.35/ 1000 days in 2012. The percentage of patients on maintenance haemodi-
alysis via a CVC dropped from 13% in 2005 to 9% in 2012. The non-tunnelled
CVC line days per year dropped from 1330 line days/ yr in 2006 to 220 line days/
yr in 2012. The percentage of incident patients with AVF improved from 15% in
2007 to 35.7% in 2012, and prevalence rate from 76% to 88%.
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